CIK 0001894562 · <br>Emerging growth company
Prime Medicine, Inc.
Sign in to watch- Ticker
- PRME
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-465-0013
- Business address
- 60 FIRST ST., CAMBRIDGE, MA, 02141
- 8-K Event Results of operations · Regulation FD disclosure
- 4/A Gift 10% owner gave 1,000,000 shares (gift)
- 4 Gift 10% owner gave 1,000,000 shares (gift)
- 4 Planned sale 10% owner sold 56,408 shares at an average $15.03 ($847,744)
- 144 Insider Sale of Securities
- 4 Planned sale 10% owner sold 73,191 shares at an average $14.93 ($1,092,435)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Planned sale 10% owner sold 57,060 shares at an average $15.00 ($855,787)
- 4 Planned sale 10% owner sold 31,703 shares at an average $14.73 ($467,135)
- 144 Insider Sale of Securities
- 4 Planned sale 10% owner sold 20,000 shares at an average $16.63 ($332,557)
- 4 Planned sale 10% owner sold 52,409 shares at an average $16.88 ($884,777)
- 144 Insider Sale of Securities
- 4 Planned sale 10% owner sold 61,856 shares at an average $14.17 ($876,198)
Page 10 of 16 · 303 filings